168 related articles for article (PubMed ID: 36706593)
1. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4
Wang F; Liu M; Ma D; Cai Z; Liu L; Wang J; Zhang W; Zhao L; Zhai C; Xu Y
Int Immunopharmacol; 2023 Mar; 116():109758. PubMed ID: 36706593
[TBL] [Abstract][Full Text] [Related]
2. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
3. The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization.
Salazar F; Hall L; Negm OH; Awuah D; Tighe PJ; Shakib F; Ghaemmaghami AM
J Allergy Clin Immunol; 2016 Jun; 137(6):1841-1851.e2. PubMed ID: 26703454
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.
Nguyen NT; Kimura A; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19961-6. PubMed ID: 21041655
[TBL] [Abstract][Full Text] [Related]
5. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
6. AhR Ligands Modulate the Differentiation of Innate Lymphoid Cells and T Helper Cell Subsets That Control the Severity of a Pulmonary Fungal Infection.
de Araújo EF; Loures FV; Preite NW; Feriotti C; Galdino NA; Costa TA; Calich VLG
Front Immunol; 2021; 12():630938. PubMed ID: 33936043
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Front Immunol; 2018; 9():950. PubMed ID: 29867939
[TBL] [Abstract][Full Text] [Related]
8. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
9. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation.
Kumar S; Wang J; Thomson AW; Gandhi CR
J Leukoc Biol; 2017 Feb; 101(2):429-438. PubMed ID: 27581538
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
14. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
Curran TA; Jalili RB; Farrokhi A; Ghahary A
Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
[TBL] [Abstract][Full Text] [Related]
15. Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase.
Huang L; Ou R; Rabelo de Souza G; Cunha TM; Lemos H; Mohamed E; Li L; Pacholczyk G; Randall J; Munn DH; Mellor AL
PLoS Pathog; 2016 May; 12(5):e1005615. PubMed ID: 27168185
[TBL] [Abstract][Full Text] [Related]
16. Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection.
Higashitani K; Kanto T; Kuroda S; Yoshio S; Matsubara T; Kakita N; Oze T; Miyazaki M; Sakakibara M; Hiramatsu N; Mita E; Imai Y; Kasahara A; Okuno A; Takikawa O; Hayashi N; Takehara T
J Gastroenterol; 2013 May; 48(5):660-70. PubMed ID: 22976933
[TBL] [Abstract][Full Text] [Related]
17. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.
Mezrich JD; Fechner JH; Zhang X; Johnson BP; Burlingham WJ; Bradfield CA
J Immunol; 2010 Sep; 185(6):3190-8. PubMed ID: 20720200
[TBL] [Abstract][Full Text] [Related]
18. Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.
Gargaro M; Vacca C; Massari S; Scalisi G; Manni G; Mondanelli G; Mazza EMC; Bicciato S; Pallotta MT; Orabona C; Belladonna ML; Volpi C; Bianchi R; Matino D; Iacono A; Panfili E; Proietti E; Iamandii IM; Cecchetti V; Puccetti P; Tabarrini O; Fallarino F; Grohmann U
Front Immunol; 2019; 10():1973. PubMed ID: 31481962
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
[TBL] [Abstract][Full Text] [Related]
20. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
